NT-proBNP Guided Discharge — EECC MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: E — A ≥30% reduction in NT-proBNP during hospitalisation for AHF is associated with improved post-discharge outcomes and suggests adequate decongestion
Serial NT-proBNP measurement during HF hospitalisation provides prognostic information and helps guide decongestion adequacy. A ≥30% reduction in NT-proBNP from admission to discharge is associated with significantly lower 30-day and 6-month mortality and readmission rates. Complete normalisation is rarely achievable and is not required. The ESC HF Guidelines recommend using NT-proBNP to guide in-hospital management and optimise the timing of discharge (Class IIa). Patients discharged with persistently elevated or rising natriuretic peptides have substantially worse outcomes and may benefit from extended hospitalisation for further decongestion and GDMT optimisation. This applies across the EF spectrum including HFpEF.
Reference: ESC (2023): Focused Update on Heart Failure